BluDog is in the business of providing wellness and optimal wellbeing. We consistently deliver great value and exceptional products to our customers.
BluDog Products (BDP) is strategically introducing a CBD oil superfood and energy drinks
(with an extended release formulation) which is water soluble and easily absorbed. Patented BDP CBD is an alternative over-the- counter therapeutic option to help relieve post-sports inflammation as well as promote relaxation and wellbeing and provide a boost of energy. BDP interacts naturally with the body’s anti-inflammatory system without any known side effects.
BluDog products are formulated with:
- Patented proprietary HempCHOICE® (PCR) hemp oil extracts which deliver a full spectrum of cannabinoids and terpenes. We use the patented VESIsorb® delivery system making the full spectrum of cannabinoids and terpenes including CBD “body ready” for improved absorption bioavailability and maximum benefits.
No other provider has our exclusive formulation for maximum absorption. Our PCR is extracted from pesticide-free hemp, is glycerin, gluten and corn syrup free, has no added sugar, and is non-GMO. All of our products are tested by a third-party lab for purity ensuring the highest quality PCR products.
The Multi-Billion $ Market
BDP is tapping into a multi-billion dollar market for effective, non-addictive and nonopioid
pain relief products that have no known side effects. With the demand for pain solutions, many prescribed products have come under scrutiny. Prescription drug abuse is currently the nation’s fastest growing drug addiction. The global nutraceuticals market reached $142.1 billion in 2011 and is expected to reach a staggering $204.8 billion by 2017, growing at a CAGR of 6.3%, according to a new market report from Transparency Market Research, Albany, NY. ** According to the American Pain Society, pain is the most common symptom that causes people to seek medical care. The global market for pain management by revenue at manufacturers’ sales levels is projected to grow from $33.6 billion in 2014 to nearly $34.8 billion in 2015, and $41.3 billion in 2020, with a compound annual growth rate (CAGR) of 3.2% between 2015 and 2020. U.S. sales account for approximately 48% of all of these sales. BDP is focusing on the over-the- counter segment of this market.*** North America enjoyed the highest market share for nutraceutical products at $56.4 billion in 2011.
Pain and inflammation are chronic issues that plague an active and aging population. Pain
has been medicated the same way for 40 years using over-the- counter pain relief products or prescription opioids. This consumer category has very few alternative solutions, creating a tremendous opportunity for innovative, ethical, quality and effective solutions.
BDP has developed proprietary innovative CBD products to fulfill the demand in the burgeoning pain relief market. BDP is poised to take advantage of the inevitable growth of the over-the- counter market by having the right products at the right time. With these marketplace forces in place there is a lack of effective, nonaddictive pain relief products creating a huge void and demand for safe innovative treatments.
The competition in the water-soluble CBD category is very limited. There are only a few companies that sell water-soluble CBD and their product offerings include only one or two items which are liquid based. Our patent offers a proprietary water-soluble CBD solution with an extended release formulation - effectively providing relief on a consistent level over time. BDP will offer a variety of ingestible and topical products, as well as a balm. (Note: There is very little data on the size and scope of the CBD market, which indicates it’s a new market on the bottom of the growth curve).
Why BluDog Products?
BDP will focus on CBD products with improved bioavailability, including water-soluble CBD. We currently hold an option to license a recently issued patent and trade secrets (patented formulation), for water-soluble CBD and its core technology that has the additional benefits of an extended release formulation. With this exclusive patent we can offer the exceptional combination of price, quality and effectiveness, not provided by the competition, creating a strong brand presence to quickly acquire market share.
Marketing & Timing
BDP will deploy highly effective marketing strategies to enter into the pain management category. The multi-billion dollar market for nutritional supplements continues to fuel growth potential in the healthcare, pharmaceutical and nutritional supplement industries. Industry analysts expect the nutrition supplement market to reach $175 billion globally by 2020. Currently, the marketing of CBD products is disjointed, unprofessional and very limited. Most CBD product providers market by word-of-mouth, clunky websites and to local retail stores. We believe by having an aggressive marketing strategy, we’ll be able to capture market share quickly and become the national leader in the CBD category. The large gap created by unmet consumer needs in an untapped market is a “perfect storm” for BDP. Our goal is to quickly acquire superior brand recognition and customer loyalty. As the first mover to sell extended release water-soluble CBD supported by sophisticated targeted and heavily branded marketing, CBD will have a superior competitive advantage. Our intention is to be the first to go mainstream with quality, effective CBD products.
**Nutraceuticals World,, Sept. 19, 2013, Industry News, Market to Reach $204.8 Billion by 2017
***The Global Market for Pain Management Drugs and Devices, September 2015;